THOMPSON SIEGEL & WALMSLEY LLC
Position in TLSI — TriSalus Life Sciences, Inc.
CIK 1008322
RICHMOND, VA
Position in TLSI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,441,229
+$106,933 QoQ
Shares Held
536,534
-8.1% QoQ
Ownership
0.871%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#10
of 82 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLSI Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $114,499,425 across 8 Medical Devices names. TLSI ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZBH |
Zimmer Biomet Holdings, Inc.
|
633,288 | $54,519,763 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
129,881 | $38,134,360 | |
| 3 | MDT |
Medtronic plc
|
139,007 | $10,874,517 | |
| 4 | QDEL |
QuidelOrtho Corp
|
420,815 | $7,372,678 | |
| 5 | TLSI |
TriSalus Life Sciences, Inc.
This page
|
536,534 | $2,441,229 | |
| 6 | GKOS |
GLAUKOS Corp
|
3,000 | $419,280 | |
| 7 | BSX |
Boston Scientific Corp
|
8,831 | $376,907 | |
| 8 | ABT |
Abbott Laboratories
|
3,975 | $360,691 |
All Filings in TLSI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,441,229 | 536,534 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,334,296 | 583,574 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||